alexa Peutz-Jegher Syndrome in Gynecologic Pathology
ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Peutz-Jegher Syndrome in Gynecologic Pathology

Ozlen Saglam*

Assistant Professor, Department of Pathology, Yale University, USA

*Corresponding Author:
Ozlen Saglam
Assistant Professor
Department of Pathology
Yale University, USA
Tel: 203-735-6010
Fax: 203-737-2922
E-mail: [email protected]

Received Date: August 06, 2011; Accepted Date: October 12, 2011; Published Date: December 06, 2011

Citation: Saglam O (2011) Peutz-Jegher Syndrome in Gynecologic Pathology. J Clinic Experiment Pathol 1:e102. doi: 10.4172/2161-0681.1000e102

Copyright: © 2011 Saglam O. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disorder characterized by melanotic macules, intestinal polyps, and an increased cancer risk [1]. There are diverse pathologic manifestations of the syndrome in females. These can present from early infancy to late adulthood either concomitantly or subsequently. There is no consensus or guidelines for cancer surveillance in PJS patients. There are occasions when the pathologist’s awareness and interpretation of the microscopic findings can contribute to the overall clinical managements of these cases. PJS is caused by mutations in the serine/threonine kinase 11 gene (LKB1, STK11) in a majority of cases [2]. Up to 25-30% of PJS patients carry a mutation in an unidentified gene that confers high susceptibility to cancer development. These patients probably have large rearrangements of LKB1, including deletions, duplications, and inversions of areas larger than an exon.

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version